🔎 Trials Near Me

Home › Multiple Sclerosis › Arizona

Pag-aaral pangklinika para sa Multiple Sclerosis sa Arizona

5 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Arizona.

Mga Lungsod sa Arizona

Opisyal na teksto ng pag-aaral (English)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Gilbert
  • TG Therapeutics Investigational Trial Site, Phoenix
  • TG Therapeutics Investigational Trial Site, Scottsdale
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195, Phoenix
  • Perseverance Research Center- Site Number : 8400138, Scottsdale
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Arizona, Tucson
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • Perseverance Research Center,LLC, Scottsdale
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06782490

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Ctr for Neurology and Spine, Phoenix
  • AZ Integrated Neuro and Spine, Phoenix
  • Center for Neurosciences, Tucson
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.